The World’s First Oncolytic Virus Drug was Launched to Treat Malignant Brain Tumor GBM
Glioblastoma multiforme (GBM) is the most aggressive malignant brain tumor in adults, with a median survival of only about ten months. Unlike low-grade gliomas (grades I and II), which grow slowly, high-grade gliomas (grades III and IV) grow much faster and can spread to other parts of the brain, resulting…...
Natural Killer (NK) Cell-based Treatment Demonstrates Its Potential to Become an Effective Novel Cancer Therapy
Natural Killer (NK) cells are specialized lymphocytes that play critical roles in the immune response against abnormal cells, including all kinds of cancer cells. Different from T cells that need to be pre-activated by antigen-presenting cells before gaining the killing power, NK cells can quickly respond to a wide variety…...
3 Important Tips For Immuno-Oncology Drug Treatment
Immuno-oncology (IO) drugs have demonstrated unprecedented benefits in the treatment of several types of cancer. The overall survival time of cancer patients treated by IO drugs have been dramatically extended, and in some cases, even late stage fatal cancers are brought into remission by the IO-based immunotherapy. IO drugs work…...
Strategic Media Partner
